STUDIO

BioStock Studio: Cereno Scientific’s CEO about the milestone in the CS1...

Last week, Spotlight-listed Cereno Scientific got the acceptance from the FDA regarding their IND application for initiating a phase II trial with CS1 in...

RECOMMENDED READING

Co-founder and CBO Niels Møller Evaxion Biotech

Evaxion Biotech leverages AI to fight cancer and infectious diseases

The development of new medicines is a long and costly process, often associated with...

Iconovo looks to the US where it now meets quality requirements

One of Iconovo's goals is to launch future inhalation products in the US, the...

EVENT